Achieve Life Sciences Inc... (ACHV)
NASDAQ: ACHV
· Real-Time Price · USD
2.96
-0.01 (-0.34%)
At close: Sep 26, 2025, 11:08 AM
-0.34% (1D)
| Bid | 2.95 |
| Market Cap | 151.45M |
| Revenue (ttm) | 228K |
| Net Income (ttm) | -50.42M |
| EPS (ttm) | -1.48 |
| PE Ratio (ttm) | -2 |
| Forward PE | -2.91 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 2.97 |
| Volume | 298,353 |
| Avg. Volume (20D) | 1,402,344 |
| Open | 2.98 |
| Previous Close | 2.97 |
| Day's Range | 2.95 - 3.01 |
| 52-Week Range | 1.84 - 5.31 |
| Beta | 1.54 |
| Ex-Dividend Date | n/a |
About ACHV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACHV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACHV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+12.02%
Achieve Life Sciences shares are trading higher af...
Unlock content with
Pro Subscription
3 months ago
-36.47%
Achieve Life Sciences shares are trading lower after the company announced a $45 million public offering.
1 month ago · seekingalpha.com
Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call TranscriptAchieve Life Sciences, Inc. (NASDAQ:ACHV ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Cindy Jacobs - Former President & Chief Medical Officer Jaime Xinos - Chief Commercial O...
1 month ago · fool.com
Achieve (ACHV) Q2 Net Loss Hits $12.7MAchieve (ACHV) Q2 Net Loss Hits $12.7M
